| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mammary Neoplasms, Experimental | 21 | 2018 | 236 | 2.740 |
Why?
|
| Mammary Glands, Animal | 18 | 2018 | 446 | 2.260 |
Why?
|
| Tumor Suppressor Protein p53 | 13 | 2018 | 727 | 1.100 |
Why?
|
| Breast Neoplasms | 16 | 2018 | 2583 | 1.030 |
Why?
|
| Precancerous Conditions | 6 | 2012 | 278 | 1.000 |
Why?
|
| Carcinogens | 8 | 2009 | 128 | 0.890 |
Why?
|
| Mammary Neoplasms, Animal | 6 | 2011 | 134 | 0.840 |
Why?
|
| Progesterone | 7 | 2005 | 427 | 0.680 |
Why?
|
| Neoplastic Stem Cells | 5 | 2016 | 331 | 0.630 |
Why?
|
| Neoplasm Transplantation | 6 | 2014 | 361 | 0.620 |
Why?
|
| Estrogens | 5 | 2005 | 423 | 0.600 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 3 | 2012 | 68 | 0.590 |
Why?
|
| Mammary Glands, Human | 4 | 2012 | 80 | 0.560 |
Why?
|
| Mice | 38 | 2019 | 17671 | 0.490 |
Why?
|
| Mice, Inbred BALB C | 14 | 2018 | 1001 | 0.480 |
Why?
|
| Stromal Cells | 3 | 2014 | 301 | 0.480 |
Why?
|
| Estrogen Receptor alpha | 5 | 2013 | 424 | 0.440 |
Why?
|
| Tamoxifen | 4 | 2018 | 344 | 0.440 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2018 | 1932 | 0.430 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 7 | 2009 | 51 | 0.420 |
Why?
|
| Lymphoma, Mantle-Cell | 1 | 2014 | 29 | 0.420 |
Why?
|
| Morphogenesis | 2 | 2012 | 192 | 0.410 |
Why?
|
| Animals | 43 | 2019 | 33185 | 0.390 |
Why?
|
| Tetrahydronaphthalenes | 2 | 2012 | 30 | 0.390 |
Why?
|
| Epithelial Cells | 10 | 2013 | 872 | 0.390 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2012 | 34 | 0.380 |
Why?
|
| Antigens, CD | 1 | 2014 | 415 | 0.370 |
Why?
|
| Proteoglycans | 1 | 2012 | 80 | 0.370 |
Why?
|
| Laminin | 1 | 2012 | 67 | 0.370 |
Why?
|
| Glycoproteins | 1 | 2014 | 337 | 0.370 |
Why?
|
| Adult Stem Cells | 1 | 2012 | 52 | 0.360 |
Why?
|
| Biocompatible Materials | 1 | 2012 | 125 | 0.350 |
Why?
|
| Aneuploidy | 4 | 2013 | 139 | 0.340 |
Why?
|
| Collagen | 1 | 2012 | 292 | 0.330 |
Why?
|
| Mammary Tumor Virus, Mouse | 3 | 2013 | 98 | 0.330 |
Why?
|
| Peptides | 1 | 2014 | 830 | 0.330 |
Why?
|
| Models, Biological | 2 | 2012 | 1373 | 0.310 |
Why?
|
| Anticarcinogenic Agents | 2 | 2009 | 46 | 0.300 |
Why?
|
| Chromosomal Instability | 3 | 2008 | 58 | 0.300 |
Why?
|
| Estradiol | 3 | 2014 | 476 | 0.290 |
Why?
|
| Cell Transformation, Neoplastic | 7 | 2018 | 606 | 0.280 |
Why?
|
| Breast | 3 | 2007 | 208 | 0.270 |
Why?
|
| Quinazolines | 1 | 2009 | 179 | 0.270 |
Why?
|
| Receptors, Estrogen | 5 | 2018 | 714 | 0.260 |
Why?
|
| Disease Models, Animal | 7 | 2013 | 4442 | 0.260 |
Why?
|
| Sulfonamides | 1 | 2009 | 279 | 0.260 |
Why?
|
| Genes, p53 | 3 | 2007 | 213 | 0.250 |
Why?
|
| Cell Growth Processes | 5 | 2013 | 60 | 0.250 |
Why?
|
| Pyrazoles | 1 | 2009 | 330 | 0.240 |
Why?
|
| Mice, Inbred NOD | 4 | 2016 | 289 | 0.240 |
Why?
|
| Mice, SCID | 4 | 2016 | 570 | 0.230 |
Why?
|
| Hyperplasia | 5 | 2008 | 184 | 0.230 |
Why?
|
| Female | 40 | 2021 | 68579 | 0.220 |
Why?
|
| Cell Cycle Proteins | 7 | 2008 | 677 | 0.210 |
Why?
|
| Cell Cycle | 3 | 2014 | 587 | 0.210 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2003 | 92 | 0.190 |
Why?
|
| Carcinogens, Environmental | 1 | 2002 | 12 | 0.180 |
Why?
|
| Progestins | 1 | 2002 | 40 | 0.180 |
Why?
|
| Rats | 8 | 2010 | 3394 | 0.180 |
Why?
|
| Separase | 3 | 2013 | 28 | 0.180 |
Why?
|
| Antineoplastic Agents, Hormonal | 3 | 2018 | 253 | 0.170 |
Why?
|
| Founder Effect | 1 | 2021 | 34 | 0.170 |
Why?
|
| Hydatidiform Mole | 1 | 2021 | 19 | 0.170 |
Why?
|
| Injections, Intralesional | 2 | 2019 | 43 | 0.170 |
Why?
|
| Graft Survival | 2 | 2012 | 455 | 0.160 |
Why?
|
| Mice, Transgenic | 7 | 2015 | 2311 | 0.160 |
Why?
|
| Cell Division | 5 | 2004 | 720 | 0.160 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2019 | 36 | 0.150 |
Why?
|
| Cyclins | 3 | 2004 | 94 | 0.150 |
Why?
|
| Immunoenzyme Techniques | 5 | 2012 | 237 | 0.140 |
Why?
|
| Antineoplastic Agents | 2 | 2019 | 1758 | 0.140 |
Why?
|
| Humans | 27 | 2021 | 127201 | 0.140 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2021 | 576 | 0.130 |
Why?
|
| Epithelium | 2 | 2012 | 340 | 0.130 |
Why?
|
| Mice, Knockout | 6 | 2009 | 3711 | 0.130 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2016 | 10 | 0.120 |
Why?
|
| Autocrine Communication | 1 | 2016 | 28 | 0.120 |
Why?
|
| Cell Line, Tumor | 7 | 2016 | 3499 | 0.120 |
Why?
|
| Polycomb Repressive Complex 1 | 1 | 2016 | 26 | 0.120 |
Why?
|
| Cell Self Renewal | 1 | 2016 | 48 | 0.120 |
Why?
|
| Endopeptidases | 2 | 2008 | 109 | 0.120 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2016 | 148 | 0.120 |
Why?
|
| Insulin-Like Growth Factor I | 4 | 2010 | 317 | 0.110 |
Why?
|
| Cell Differentiation | 3 | 2012 | 1854 | 0.110 |
Why?
|
| Influenza Vaccines | 1 | 2019 | 481 | 0.110 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2016 | 774 | 0.110 |
Why?
|
| Neoplasms | 2 | 2019 | 2856 | 0.110 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2007 | 478 | 0.110 |
Why?
|
| Disease Progression | 3 | 2013 | 2117 | 0.110 |
Why?
|
| Interleukin-8 | 1 | 2015 | 203 | 0.110 |
Why?
|
| Immunotherapy | 1 | 2019 | 741 | 0.110 |
Why?
|
| AC133 Antigen | 1 | 2014 | 35 | 0.110 |
Why?
|
| GTP Phosphohydrolases | 1 | 2015 | 157 | 0.110 |
Why?
|
| Leukocyte Common Antigens | 1 | 2014 | 83 | 0.110 |
Why?
|
| Janus Kinase 2 | 1 | 2015 | 135 | 0.110 |
Why?
|
| Pregnancy | 8 | 2021 | 7380 | 0.110 |
Why?
|
| Cell Survival | 1 | 2016 | 841 | 0.100 |
Why?
|
| Estrogen Antagonists | 1 | 2014 | 93 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2014 | 80 | 0.100 |
Why?
|
| Blotting, Western | 4 | 2013 | 1014 | 0.100 |
Why?
|
| Culture Media | 1 | 2014 | 173 | 0.100 |
Why?
|
| Coculture Techniques | 1 | 2014 | 230 | 0.100 |
Why?
|
| 14-3-3 Proteins | 1 | 2013 | 56 | 0.100 |
Why?
|
| Heterozygote | 2 | 2021 | 690 | 0.100 |
Why?
|
| Immunophenotyping | 1 | 2014 | 330 | 0.100 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2013 | 43 | 0.100 |
Why?
|
| Antigens, CD19 | 1 | 2014 | 171 | 0.100 |
Why?
|
| Cell Proliferation | 5 | 2016 | 2397 | 0.100 |
Why?
|
| Cell Size | 1 | 2013 | 79 | 0.100 |
Why?
|
| Nicotinic Acids | 1 | 2012 | 8 | 0.100 |
Why?
|
| Apoptosis | 4 | 2014 | 1811 | 0.090 |
Why?
|
| Cell Separation | 1 | 2013 | 219 | 0.090 |
Why?
|
| Immunohistochemistry | 4 | 2013 | 1597 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 3 | 2014 | 82 | 0.090 |
Why?
|
| Bone Density Conservation Agents | 1 | 2012 | 57 | 0.090 |
Why?
|
| Translocation, Genetic | 1 | 2014 | 348 | 0.090 |
Why?
|
| Stem Cell Niche | 1 | 2012 | 57 | 0.090 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2012 | 53 | 0.090 |
Why?
|
| Transcriptome | 1 | 2018 | 1053 | 0.090 |
Why?
|
| Multipotent Stem Cells | 1 | 2011 | 21 | 0.090 |
Why?
|
| Fetal Blood | 1 | 2012 | 173 | 0.090 |
Why?
|
| Drug Combinations | 1 | 2012 | 270 | 0.090 |
Why?
|
| Cells, Cultured | 2 | 2018 | 2897 | 0.090 |
Why?
|
| Antigens, Viral, Tumor | 1 | 2010 | 44 | 0.080 |
Why?
|
| DNA-Binding Proteins | 2 | 2009 | 1891 | 0.080 |
Why?
|
| Neoplasm Invasiveness | 1 | 2012 | 636 | 0.080 |
Why?
|
| Neoplasm Metastasis | 2 | 2013 | 686 | 0.080 |
Why?
|
| Immunocompromised Host | 1 | 2012 | 302 | 0.080 |
Why?
|
| Mice, Inbred Strains | 1 | 2010 | 291 | 0.080 |
Why?
|
| Parity | 1 | 2010 | 81 | 0.080 |
Why?
|
| Genetic Association Studies | 1 | 2013 | 808 | 0.080 |
Why?
|
| Sarcoma | 1 | 2012 | 205 | 0.080 |
Why?
|
| Growth Hormone | 1 | 2010 | 125 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2021 | 2746 | 0.080 |
Why?
|
| Adenocarcinoma | 2 | 2013 | 973 | 0.080 |
Why?
|
| Melanoma | 1 | 2016 | 898 | 0.080 |
Why?
|
| Celecoxib | 1 | 2009 | 32 | 0.070 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2009 | 50 | 0.070 |
Why?
|
| Wnt1 Protein | 1 | 2009 | 74 | 0.070 |
Why?
|
| Stem Cells | 1 | 2013 | 683 | 0.070 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2012 | 518 | 0.070 |
Why?
|
| Prostatic Neoplasms | 1 | 2016 | 1396 | 0.070 |
Why?
|
| Chloroquine | 1 | 2007 | 30 | 0.070 |
Why?
|
| Repressor Proteins | 2 | 2019 | 763 | 0.070 |
Why?
|
| Osteoclasts | 1 | 2007 | 64 | 0.070 |
Why?
|
| Mutation | 1 | 2021 | 5947 | 0.070 |
Why?
|
| ErbB Receptors | 1 | 2009 | 285 | 0.070 |
Why?
|
| Cyclooxygenase 2 | 1 | 2007 | 126 | 0.070 |
Why?
|
| Time Factors | 3 | 2013 | 6160 | 0.070 |
Why?
|
| Lactation | 2 | 2005 | 195 | 0.060 |
Why?
|
| Incidence | 3 | 2013 | 3260 | 0.060 |
Why?
|
| Phenotype | 3 | 2013 | 4307 | 0.060 |
Why?
|
| Centrosome | 2 | 2007 | 24 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 2 | 2004 | 57 | 0.060 |
Why?
|
| Risk | 1 | 2008 | 736 | 0.060 |
Why?
|
| Mice, Nude | 2 | 2018 | 708 | 0.060 |
Why?
|
| RNA-Binding Proteins | 1 | 2009 | 533 | 0.060 |
Why?
|
| Mad2 Proteins | 1 | 2004 | 7 | 0.060 |
Why?
|
| Cell Line, Transformed | 1 | 2004 | 156 | 0.060 |
Why?
|
| Carcinoma | 1 | 2007 | 279 | 0.050 |
Why?
|
| Flow Cytometry | 3 | 2013 | 755 | 0.050 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2004 | 12 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2018 | 946 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 4 | 2019 | 4513 | 0.050 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2004 | 134 | 0.050 |
Why?
|
| Genomics | 1 | 2011 | 1548 | 0.050 |
Why?
|
| Base Sequence | 2 | 2004 | 2759 | 0.050 |
Why?
|
| Calcium-Binding Proteins | 1 | 2004 | 327 | 0.050 |
Why?
|
| Bone Neoplasms | 1 | 2007 | 429 | 0.050 |
Why?
|
| Phosphorylation | 3 | 2013 | 1537 | 0.050 |
Why?
|
| Proto-Oncogenes | 1 | 2002 | 36 | 0.050 |
Why?
|
| Ovariectomy | 1 | 2003 | 166 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 3264 | 0.050 |
Why?
|
| RNA, Messenger | 3 | 2014 | 2540 | 0.050 |
Why?
|
| Receptors, Progesterone | 1 | 2005 | 663 | 0.050 |
Why?
|
| BRCA2 Protein | 1 | 2002 | 50 | 0.050 |
Why?
|
| Carcinoma in Situ | 1 | 2002 | 72 | 0.040 |
Why?
|
| Transforming Growth Factor beta | 1 | 2004 | 445 | 0.040 |
Why?
|
| Radiation Dosage | 1 | 2002 | 126 | 0.040 |
Why?
|
| Live Birth | 1 | 2021 | 66 | 0.040 |
Why?
|
| CD24 Antigen | 2 | 2013 | 30 | 0.040 |
Why?
|
| Chromosome Aberrations | 1 | 2004 | 570 | 0.040 |
Why?
|
| Integrin beta1 | 2 | 2013 | 54 | 0.040 |
Why?
|
| In Vitro Techniques | 1 | 2002 | 824 | 0.040 |
Why?
|
| Protein Kinases | 1 | 2002 | 318 | 0.040 |
Why?
|
| Models, Animal | 1 | 2002 | 452 | 0.040 |
Why?
|
| Mexico | 1 | 2021 | 193 | 0.040 |
Why?
|
| Aging | 1 | 2007 | 1197 | 0.040 |
Why?
|
| Rats, Inbred WF | 3 | 2007 | 16 | 0.040 |
Why?
|
| Biomarkers, Tumor | 1 | 2008 | 1560 | 0.040 |
Why?
|
| Squalene | 1 | 2019 | 25 | 0.040 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2019 | 30 | 0.040 |
Why?
|
| Models, Genetic | 1 | 2002 | 742 | 0.040 |
Why?
|
| Haplotypes | 1 | 2021 | 525 | 0.040 |
Why?
|
| Immunity, Cellular | 1 | 2019 | 196 | 0.040 |
Why?
|
| Interleukin-10 | 1 | 2019 | 181 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 1232 | 0.040 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2018 | 16 | 0.040 |
Why?
|
| DNA | 1 | 2004 | 1421 | 0.040 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2019 | 185 | 0.040 |
Why?
|
| Seasons | 1 | 2019 | 318 | 0.030 |
Why?
|
| Adjuvants, Immunologic | 1 | 2019 | 380 | 0.030 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2018 | 198 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2019 | 685 | 0.030 |
Why?
|
| Skin | 1 | 2019 | 517 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2019 | 440 | 0.030 |
Why?
|
| B-Lymphocytes | 1 | 2019 | 516 | 0.030 |
Why?
|
| Pregnancy, Animal | 2 | 2010 | 68 | 0.030 |
Why?
|
| Genotype | 1 | 2002 | 2598 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2005 | 2344 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 6685 | 0.030 |
Why?
|
| Tumor Microenvironment | 1 | 2019 | 628 | 0.030 |
Why?
|
| Genes, ras | 1 | 2015 | 99 | 0.030 |
Why?
|
| Methylnitrosourea | 2 | 2007 | 15 | 0.030 |
Why?
|
| Aurora Kinases | 2 | 2007 | 26 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2008 | 1005 | 0.030 |
Why?
|
| Aurora Kinase A | 2 | 2007 | 35 | 0.030 |
Why?
|
| Signal Transduction | 3 | 2015 | 4481 | 0.030 |
Why?
|
| Vaccination | 1 | 2019 | 1004 | 0.030 |
Why?
|
| Mice, Mutant Strains | 2 | 2005 | 365 | 0.030 |
Why?
|
| Etoposide | 1 | 2014 | 109 | 0.030 |
Why?
|
| Cyclin D1 | 2 | 2005 | 108 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2014 | 207 | 0.030 |
Why?
|
| Paclitaxel | 1 | 2014 | 128 | 0.030 |
Why?
|
| Influenza, Human | 1 | 2019 | 674 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2013 | 135 | 0.020 |
Why?
|
| Receptors, Androgen | 1 | 2016 | 402 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 414 | 0.020 |
Why?
|
| Spheroids, Cellular | 1 | 2013 | 58 | 0.020 |
Why?
|
| Doxorubicin | 1 | 2014 | 286 | 0.020 |
Why?
|
| Cellular Senescence | 1 | 2014 | 183 | 0.020 |
Why?
|
| Biomarkers | 2 | 2013 | 3234 | 0.020 |
Why?
|
| Demography | 1 | 2013 | 238 | 0.020 |
Why?
|
| Skin Neoplasms | 1 | 2019 | 880 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2013 | 748 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2014 | 649 | 0.020 |
Why?
|
| Lung | 1 | 2019 | 1522 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2013 | 560 | 0.020 |
Why?
|
| Galactosides | 1 | 2011 | 11 | 0.020 |
Why?
|
| Claudins | 1 | 2011 | 30 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2013 | 324 | 0.020 |
Why?
|
| Stem Cell Transplantation | 1 | 2013 | 231 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2013 | 898 | 0.020 |
Why?
|
| Risk Factors | 1 | 2005 | 10602 | 0.020 |
Why?
|
| Gene Expression Profiling | 2 | 2008 | 1760 | 0.020 |
Why?
|
| Genes, Neoplasm | 1 | 2011 | 80 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2011 | 170 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2012 | 642 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 524 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2011 | 410 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2019 | 1493 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2010 | 292 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2010 | 307 | 0.020 |
Why?
|
| Metaphase | 1 | 2008 | 31 | 0.020 |
Why?
|
| Anaphase | 1 | 2008 | 13 | 0.020 |
Why?
|
| Chromatids | 1 | 2008 | 32 | 0.020 |
Why?
|
| Colony-Forming Units Assay | 1 | 2008 | 60 | 0.020 |
Why?
|
| Cell Transplantation | 1 | 2008 | 35 | 0.020 |
Why?
|
| Tetracycline | 1 | 2008 | 80 | 0.020 |
Why?
|
| Aged | 2 | 2019 | 20414 | 0.020 |
Why?
|
| Nucleotidyltransferases | 1 | 2008 | 46 | 0.020 |
Why?
|
| Neoplasms, Experimental | 1 | 2009 | 203 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 787 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2008 | 297 | 0.020 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2007 | 54 | 0.020 |
Why?
|
| Dinoprostone | 1 | 2007 | 67 | 0.020 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2007 | 97 | 0.020 |
Why?
|
| Polyploidy | 1 | 2007 | 16 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2010 | 1127 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2013 | 1236 | 0.020 |
Why?
|
| Karyotyping | 1 | 2007 | 312 | 0.020 |
Why?
|
| Middle Aged | 2 | 2019 | 27789 | 0.020 |
Why?
|
| Homozygote | 1 | 2008 | 540 | 0.020 |
Why?
|
| United States | 1 | 2002 | 11360 | 0.020 |
Why?
|
| Cell Line | 1 | 2011 | 2565 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2008 | 444 | 0.020 |
Why?
|
| Ki-67 Antigen | 1 | 2005 | 100 | 0.010 |
Why?
|
| DNA Copy Number Variations | 1 | 2011 | 1004 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2005 | 120 | 0.010 |
Why?
|
| Adult | 2 | 2019 | 30513 | 0.010 |
Why?
|
| Menopause | 1 | 2005 | 84 | 0.010 |
Why?
|
| Pituitary Gland | 1 | 2005 | 77 | 0.010 |
Why?
|
| Genome, Human | 1 | 2011 | 1279 | 0.010 |
Why?
|
| MicroRNAs | 1 | 2011 | 873 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 2004 | 56 | 0.010 |
Why?
|
| Antigens, Neoplasm | 1 | 2007 | 398 | 0.010 |
Why?
|
| Nuclear Receptor Coactivator 3 | 1 | 2005 | 253 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2013 | 4976 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2004 | 110 | 0.010 |
Why?
|
| Cyclin D2 | 1 | 2002 | 14 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2005 | 477 | 0.010 |
Why?
|
| Xenopus Proteins | 1 | 2002 | 59 | 0.010 |
Why?
|
| Thymidine Kinase | 1 | 2002 | 88 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 2002 | 135 | 0.010 |
Why?
|
| Ganciclovir | 1 | 2002 | 101 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2005 | 588 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2002 | 435 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2004 | 826 | 0.010 |
Why?
|
| Male | 3 | 2016 | 62767 | 0.010 |
Why?
|
| Gene Expression | 1 | 2004 | 1485 | 0.010 |
Why?
|
| Adenoviridae | 1 | 2002 | 573 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2002 | 1484 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 9693 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2002 | 2543 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2002 | 972 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2002 | 3587 | 0.010 |
Why?
|
| Antiviral Agents | 1 | 2002 | 776 | 0.010 |
Why?
|